Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

New era of affordable insulin New era of affordable insulin
Blog October 13, 2020
New era of affordable insulin
Acute respiratory distress syndrome doubles in U.S. during COVID-19 Acute respiratory distress syndrome doubles in U.S. during COVID-19
Blog October 9, 2020
Acute respiratory distress syndrome doubles in U.S. during COVID-19
Blog October 6, 2020
Digital innovation in drug development: Perspectives from pharma, tech and regulatory experts
Role of advanced IDNs grows as COVID-19 shifts market dynamics Role of advanced IDNs grows as COVID-19 shifts market dynamics
Blog September 29, 2020
Role of advanced IDNs grows as COVID-19 shifts market dynamics
Physician practice ownership set for radical change as COVID-19 strains finances Physician practice ownership set for radical change as COVID-19 strains finances
Blog September 29, 2020
Physician practice ownership set for radical change as COVID-19 strains finances
Telehealth here to stay as unprecedented times drive innovation Telehealth here to stay as unprecedented times drive innovation
Blog September 29, 2020
Telehealth here to stay as unprecedented times drive innovation
Hospital infections dip during pandemic Hospital infections dip during pandemic
Blog September 29, 2020
Hospital infections dip during pandemic
Key ESMO Highlights 2020 Key ESMO Highlights 2020
Blog September 28, 2020
Key ESMO Highlights 2020
GSK’s first-in-class anti-BCMA therapy wins regulatory approval GSK’s first-in-class anti-BCMA therapy wins regulatory approval
Blog September 8, 2020
GSK’s first-in-class anti-BCMA therapy wins regulatory approval
Precision search and easy full-text access with dialog solutions and research solutions Precision search and easy full-text access with dialog solutions and research solutions
Blog September 3, 2020
Precision search and easy full-text access with dialog solutions and research solutions